We are 2-Chlorobutyric Acid CAS:4170-24-5 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: ： 2-Chlorobutyric Acid
Butanoic acid, 2-chloro-
Molecular Formula: C4H7ClO2
Physical and Chemical Properties:
Boiling point: 90-92ºC (12 mmHg)
Flash point: 76.7ºC
Refractive index: 1.439
Light yellow liquid
Moisture Content: less than 0.3%
Impurity: less than 0.3%
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Levetiracetam CAS:102767-28-2
Related News: At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.1-Chloro-5-fluoropentane The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).2- (clorometil) -2- (4-clorofenil) hexanenitrilo CAS:98595-02-9 The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).3-(2-Methoxy-5-methylphenyl)-3-phenylpropanol Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).